SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-18-007936
Filing Date
2018-06-20
Accepted
2018-06-20 14:38:18
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ff32018_therapixbio.htm F-3 572488
2 FORM OF SENIOR INDENTURE ff32018ex4-3_therapix.htm EX-4.3 250006
3 FORM OF SUBORDINATED INDENTURE ff32018ex4-4_therapix.htm EX-4.4 336655
4 OPINION OF HORN & CO. - LAW OFFICES ff32018ex5-1_therapix.htm EX-5.1 36862
5 OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C ff32018ex5-2_therapix.htm EX-5.2 21760
6 CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL ff32018ex23-1_therapix.htm EX-23.1 3492
7 GRAPHIC image_001.jpg GRAPHIC 5806
8 GRAPHIC ex5-2_001.jpg GRAPHIC 8807
  Complete submission text file 0001213900-18-007936.txt   1242695
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: F-3 | Act: 33 | File No.: 333-225745 | Film No.: 18909305
SIC: 2834 Pharmaceutical Preparations